Article, 2024

The role of fibrosis in cardiomyopathies: An opportunity to develop novel biomarkers of disease activity

MATRIX BIOLOGY, ISSN 0945-053X, Volume 128, Pages 65-78, 10.1016/j.matbio.2024.02.008

Contributors

Angeli, Elisavet 0000-0003-4104-909X (Corresponding author) [1] [2] Jordan, Maria [3] [4] Otto, Mandy [3] [4] Stojanovic, Stevan D. [5] Karsdal, Morten [1] Bauersachs, Johann [5] Thum, Thomas [3] [4] [5] Fiedler, Jan [3] [4] Genovese, Federica 0000-0003-1984-1881 [2]

Affiliations

  1. [1] Nordic Biosci A S, Herlev, Denmark
    2. [NORA names: Nordic Bioscience; Private Research; Denmark; Europe, EU; Nordic; OECD];
  2. [2] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark
    3. [NORA names: KU University of Copenhagen; University; Denmark; Europe, EU; Nordic; OECD];
  3. [3] Fraunhofer Cluster Excellence Immune Mediated Dis, Hannover, Germany
    4. [NORA names: Germany; Europe, EU; OECD];
  4. [4] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany
    5. [NORA names: Germany; Europe, EU; OECD];
  5. [5] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany
    6. [NORA names: Germany; Europe, EU; OECD]

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Keywords

Biomarkers, Cardiomyopathies, Extracellular matrix, Fibrosis

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+